The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumQuick Picks - Shares of Optimer Pharmaceuticals (NASDAQ:OPTR) are off 6% from their peak earlier this month, and have fallen nearly 15% from their 52-week high, as investors … Continue Reading
Read nowLong Ideas - SciClone Pharmaceuticals (NASDAQ:SCLN) announced Tuesday morning that, as expected, the Chinese government has reduced the list price for Zadaxin. This action has been expected for … Continue Reading
Read nowLong Ideas - Merge Healthcare (NASDAQ:MRGE) fell hard earlier this year when the company announced changes to its business model. In particular, the company moved to offer subscription-based … Continue Reading
Read nowMost Popular - Shares of Navidea Biopharmaceuticals (NASDAQ:NAVB) are trading up 9% Monday on optimism over a quick resubmission of information in support of Lymphoseek’ approval following a … Continue Reading
Read nowMost Popular - Investors received word Monday morning of a positive ruling on Jazz Pharmaceuticals’ (NASDAQ:JAZZ)Â Xyrem patent case with Roxane Laboratories, a subsidiary of Boehringer Ingelheim. In 2010, … Continue Reading
Read nowQuick Picks - Targacept (NASDAQ:TRGT) announced Monday morning that its Phase II trial for TC-5619 in the treatment of inattentive-predominant attention deficit/hyperactivity disorder (ADHDi) did not meet its … Continue Reading
Read nowMost Popular - Complete Genomics (NASDAQ:GNOM) announced that it has reached buy-out terms with Chinese pharmaceutical company BGI-Shenzhen, in which GNOM will be sold for $117.6M, or $3.15/share. … Continue Reading
Read now
